A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis
Clinical trial NCT05314517 · TERMINATED
Trial details
- NCT number
- NCT05314517
- Sponsor
- Kinevant Sciences GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-31
- Primary completion
- 2024-10-16
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.